Skip to main content
JACC: CardioOncology logoLink to JACC: CardioOncology
. 2022 Dec 20;4(5):732. doi: 10.1016/j.jaccao.2022.11.007

Correction

PMCID: PMC9830187  PMID: 36636440

Li Y, Sun L, Burstein DS, Getz KD

Considerations of Competing Risks Analysis in Cardio-Oncology Studies: JACC: CardioOncology State-of-the-Art Review

J Am Coll Cardiol CardioOnc 2022;4(3):287-301

In the Central Illustration, the text in Q1 was “Occurrence of Z (primary event of interest) precludes observation of Y (secondary event that is a potential competing risk)” but should have been “Occurrence of Z (secondary event that is a potential competing risk) precludes observation of Y (primary event of interest)”.

Central Illustration.

Central Illustration

Framework for Assessing Competing Risk Conceptually

Here Y represents the primary event of interest, and Z represents the secondary event that is potentially a competing risk for Y. Examples A (classic competing risk), B (composite outcome), and C (dependent censoring) are further explained in the text (in the section “Competing Risks Overview”), and examples D (intermediate event) and E (loss to follow-up) are explained in the Supplemental Appendix. Q1 = Question 1; Q2 = Question 2; Q3 = Question 3; Q4 = Question 4; Q5 = Question 5; Q6 = Question 6.

The authors apologize for this error. The current online version has been corrected.


Articles from JACC: CardioOncology are provided here courtesy of Elsevier

RESOURCES